124 related articles for article (PubMed ID: 4713306)
1. Reversal of some therapeutic effects of an antipsychotic agent by an antiparkinsonism drug.
Singh MM; Smith JM
J Nerv Ment Dis; 1973 Jul; 157(1):50-8. PubMed ID: 4713306
[No Abstract] [Full Text] [Related]
2. Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses?
Neu C; Dimascio A; Demirgian E
Curr Ther Res Clin Exp; 1972 May; 14(5):246-51. PubMed ID: 4623975
[No Abstract] [Full Text] [Related]
3. Evaluating the long-term need for antiparkinson drugs by chronic schizophrenics.
Klett CJ; Caffey E
Arch Gen Psychiatry; 1972 Apr; 26(4):374-9. PubMed ID: 4552131
[No Abstract] [Full Text] [Related]
4. Sleeplessness in acute and chronic schizophrenia--response to haloperidol and anti-parkinsonism agents.
Singh MM; Smith JM
Psychopharmacologia; 1973 Feb; 29(1):21-32. PubMed ID: 4571938
[No Abstract] [Full Text] [Related]
5. The effect of benztropine mesylate in the rabbit syndrome and tardive dyskinesia.
Sovner R; Dimascio A
Am J Psychiatry; 1977 Nov; 134(11):1301-2. PubMed ID: 910992
[No Abstract] [Full Text] [Related]
6. Comparison of benztropine mesylate and amantadine HCl in neuroleptic-induced extrapyramidal symptoms.
Stenson RL; Donion PT; Meyer JE
Compr Psychiatry; 1976; 17(6):763-8. PubMed ID: 791573
[No Abstract] [Full Text] [Related]
7. A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics.
Singh MM; Kay SR
Psychopharmacologia; 1975 Aug; 43(2):103-13. PubMed ID: 1103205
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic reversal with benxtropine in schizophrenics. Practical and theoretical significance.
Singh MM; Kay SR
J Nerv Ment Dis; 1975 Apr; 160(4):258-66. PubMed ID: 1097596
[TBL] [Abstract][Full Text] [Related]
9. A quantitative study of neuroleptic-induced extrapyramidal symptoms and their response to dexetimide, a potent and long-acting antiparkinsonian agent.
Dom R; Van Lommel R; Baro F
Acta Psychiatr Scand; 1971; 47(4):399-410. PubMed ID: 4947805
[No Abstract] [Full Text] [Related]
10. Ethylbenzatropine for acute neurological and mental side effects after tranquillisers.
Molcan J; Floreánová L; Polák L
Act Nerv Super (Praha); 1972; 14(2):97. PubMed ID: 5040183
[No Abstract] [Full Text] [Related]
11. Loxapine: a six-month evaluation in severely ill schizophrenic patients.
Gallant DM; Bishop G; Steel CA; Bishop MP
Curr Ther Res Clin Exp; 1973 Apr; 15(4):205-9. PubMed ID: 4633281
[No Abstract] [Full Text] [Related]
12. Some methodological considerations in the evaluation of drug-induced extrapyramidal disorders: a study of Ex10-029, a new morphanthridine derivative.
Simpson GM; Beckles D; Isalski Z; Lee JH
J Clin Pharmacol New Drugs; 1972 Apr; 12(4):142-52. PubMed ID: 4553448
[No Abstract] [Full Text] [Related]
13. Benztropine prophylaxis of dystonic reactions.
Stern TA; Anderson WH
Psychopharmacology (Berl); 1979 Mar; 61(3):261-2. PubMed ID: 36644
[TBL] [Abstract][Full Text] [Related]
14. A double-blind clinical evaluation of penfluridol (R 16 341) as a maintenance therapy in schizophrenia.
Vandecasteele AJ; Vereecken JL
Acta Psychiatr Scand; 1974; 50(3):346-53. PubMed ID: 4609288
[No Abstract] [Full Text] [Related]
15. Sudden dysphagia with uvular enlargement following the initiation of risperidone which responded to benztropine: was this an extrapyramidal side effect?
Nair S; Saeed O; Shahab H; Sedky K; Garver D; Lippmann S
Gen Hosp Psychiatry; 2001; 23(4):231-2. PubMed ID: 11569473
[No Abstract] [Full Text] [Related]
16. Basic principles of rapid neuroleptization.
Mason AS; Granacher RP
Dis Nerv Syst; 1976 Oct; 37(10):547-51. PubMed ID: 9267
[No Abstract] [Full Text] [Related]
17. Pimozide treatment of chronic schizophrenics as compared with haloperidol and penfluridol maintenance treatment. A multidisciplinary approach.
Baro F; Van Lommel R; Dom R; De Mesmaecker L
Acta Psychiatr Belg; 1972 Mar; 72(2):199-214. PubMed ID: 5056015
[No Abstract] [Full Text] [Related]
18. A crossover study of clocapramine and haloperidol in chronic schizophrenia.
Yamagami S
J Int Med Res; 1985; 13(6):301-10. PubMed ID: 4076529
[TBL] [Abstract][Full Text] [Related]
19. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.
Cesková E; Svestka J
Pharmacopsychiatry; 1993 Jul; 26(4):121-4. PubMed ID: 7694306
[TBL] [Abstract][Full Text] [Related]
20. Extrapyramidal side effects in chlorpromazine recipients: emergence according to benztropine prophylaxis.
Swett C; Cole JO; Shapiro S; Slone D
Arch Gen Psychiatry; 1977 Aug; 34(8):942-3. PubMed ID: 889418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
